Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
15 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Belite Bio, Inc.

18 Feb 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Belite Bio, Inc.

30 Jan 2026

Belite Bio, Inc securities registration filing

Belite Bio, Inc filed a registration or prospectus document concerning securities.

11 Dec 2025

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Belite Bio, Inc.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$352.93M
Total assets (USD)$780.56M
Total liabilities (USD)$10.07M
Shareholders' equity (USD)$770.49M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $236.86
53.1% upside potential
📈
Strong Buy
Unavailable
👍
Buy
7
⏸️
Hold
0
📉
Sell
0
7 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 200.00–303.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
1
Oct 2026
Scholl Hendrik Peter
Chief Medical Officer
Open-market sale
$165.32 per share
500 shares
SEC Form 4
8
Sep 2026
Lin Yu-Hsin
Director, Chief Executive Officer
Open-market sale
$196.56 per share
26,000 shares
SEC Form 4
8
Sep 2026
Chuang Hao-Yuan
Director, Chief Financial Officer
Open-market sale
$196.42 per share
17,962 shares
SEC Form 4
4
Sep 2026
Lin Yu-Hsin
Director, Chief Executive Officer
Open-market sale
$187.71 per share
74,435 shares
SEC Form 4
4
Sep 2026
Chuang Hao-Yuan
Director, Chief Financial Officer
Open-market sale
$187.64 per share
49,433 shares
SEC Form 4
12
Aug 2026
Chuang Hao-Yuan
Director, Chief Financial Officer
Open-market sale
$180.35 per share
367 shares
SEC Form 4
12
Aug 2026
Lin Yu-Hsin
Director, Chief Executive Officer
Open-market sale
$180.35 per share
365 shares
SEC Form 4
18
Jun 2026
Scholl Hendrik Peter
Chief Medical Officer
Open-market sale
$145.24 per share
10,000 shares
SEC Form 4
16
Jun 2026
Scholl Hendrik Peter
Chief Medical Officer
Open-market sale
$140.57 per share
10,000 shares
SEC Form 4
7
May 2026
MATA NATHAN L.
Chief Scientific Officer
Open-market sale
$153.21 per share
666 shares
SEC Form 4

Top Shareholders

Darwin Global Management, Ltd.
3,077,219 shares
0.648% change
6/30/2026
Paradigm Biocapital Advisors Lp
1,232,877 shares
10.593% change
6/30/2026
Rtw Investments, Lp
715,332 shares
0% change
6/30/2026
Millennium Management Llc
494,564 shares
-13.248% change
6/30/2026
Maverick Capital Ltd
396,311 shares
New% change
6/30/2026
Eventide Asset Management, Llc
390,829 shares
9.277% change
6/30/2026
Deerfield Management Company, L.P.
357,199 shares
17.495% change
6/30/2026
Holocene Advisors, Lp
251,035 shares
-49.234% change
6/30/2026
Logos Global Management Lp
250,000 shares
New% change
6/30/2026
Morgan Stanley
235,071 shares
16.713% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago